Nonmodulation and essential hypertension

Curr Hypertens Rep. 2006 May;8(2):127-31. doi: 10.1007/s11906-006-0008-9.

Abstract

Nonmodulation is a process in which there is a disorder in angiotensin-dependent control of the renal circulation and adrenal aldosterone release. The abnormalities are associated with an inability to handle a sodium load and salt-sensitive hypertension. All of the features are corrected by angiotensin-converting enzyme inhibition. A striking family history of hypertension and concordance of responses to angiotensin II in sibling pairs have suggested a familial factor. Genes governing renin substrate (angiotensinogen) production showed gene polymorphisms in nonmodulators. As nonmodulation occurs in approximately 40% of patients with essential hypertension, clearly other genes must contribute.

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensinogen / genetics*
  • Angiotensinogen / metabolism
  • Humans
  • Hypertension / genetics
  • Hypertension / metabolism*
  • Kidney / blood supply
  • Kidney / metabolism
  • Peptidyl-Dipeptidase A / drug effects
  • Peptidyl-Dipeptidase A / metabolism
  • Polymorphism, Genetic
  • Renal Circulation*
  • Renin / metabolism*
  • Renin-Angiotensin System* / drug effects
  • Sodium / metabolism

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensinogen
  • Sodium
  • Peptidyl-Dipeptidase A
  • Renin